Barclays Downgrades Qiagen to Equal-Weight, Lowers Price Target to $53
Benzinga Newsdesk 3 days ago
Analyst RatingsNewsDowngradesPrice Target
Barclays analyst Luke Sergott downgrades Qiagen (NYSE:QGEN) from Overweight to Equal-Weight and lowers the price target from $55 to $53.
Barclays analyst Luke Sergott downgrades Qiagen (NYSE:QGEN) from Overweight to Equal-Weight and lowers the price target from $55 to $53.